tradingkey.logo
tradingkey.logo
Pesquisar

Treace Medical Concepts Inc

TMCI
Adicionar à lista de desejos
4.210USD
-0.020-0.47%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
272.75MValor de mercado
PerdaP/L TTM

Mais detalhes de Treace Medical Concepts Inc Empresa

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Informações de Treace Medical Concepts Inc

Código da empresaTMCI
Nome da EmpresaTreace Medical Concepts Inc
Data de listagemApr 23, 2021
CEOTreace (John T)
Número de funcionários477
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 23
Endereço100 Palmetto Park Place
CidadePONTE VEDRA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32081
Telefone19043735940
Sitehttps://www.treace.com/
Código da empresaTMCI
Data de listagemApr 23, 2021
CEOTreace (John T)

Executivos da empresa Treace Medical Concepts Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
546.36K
+5.49%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
200.76K
-96.89%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
161.06K
-69.82%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
73.65K
+40.73%
Mr. Gaetano Guglielmino
Mr. Gaetano Guglielmino
Chief Commercial Officer
Chief Commercial Officer
68.65K
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Treace Medical Concepts Inc?

Os cinco principais acionistas de Treace Medical Concepts Inc são: Mr. John K. Bakewell

Quantas instituições possuem ações da Treace Medical Concepts Inc (TMCI)?

Em 2026Q1, 342 instituições possuíam ações da Treace Medical Concepts Inc, com valor de mercado aproximado de 37.97M, representando 58.61% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -15683733.00.